B. Riley Issues Negative Forecast for CGTX Earnings
Cognition Therapeutics, Inc. (NASDAQ:CGTX – Free Report) – Research analysts at B. Riley cut their Q2 2025 earnings per share (EPS) estimates for Cognition Therapeutics in a research note issued on Thursday, May 29th. B. Riley analyst M. Mamtani now expects that the company will post earnings of ($0.14) per share for the quarter, down […]
Cognition Therapeutics, Inc. (NASDAQ:CGTX – Free Report) – Research analysts at B. Riley cut their Q2 2025 earnings per share (EPS) estimates for Cognition Therapeutics in a research note issued on Thursday, May 29th. B. Riley analyst M. Mamtani now expects that the company will post earnings of ($0.14) per share for the quarter, down […]
